Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Bad
|
New words:
abroad, adequacy, amtrust, ascertain, Chancellor, chart, circumvention, civil, confidence, constituting, consumer, create, created, criminal, curb, DAC, delirium, deter, discourage, District, downturn, effort, employee, energy, estate, evidence, flow, fracture, fuel, fundamental, hip, inability, infusion, insolvency, instability, ledger, Likewise, lose, mortgage, Northern, par, placebo, precision, premerger, prevail, promptly, real, recession, recover, regional, repurchase, roll, scrutiny, slower, strong, symptomatology, tighter, treated, Unanticipated, underperformance, underwriter, unemployment, unqualified, wide
Filing tables
Filing exhibits
ATNF similar filings
Filing view
External links
Exhibit 32.2
180 LIFE SCIENCES CORP.
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Ozan Pamir, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report of 180 Life Sciences Corp. on Form 10-Q for the quarterly period ended June 30, 2022, (i) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (ii) that the information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of 180 Life Sciences Corp. at the dates and for the periods indicated.
By: | /s/ Ozan Pamir | |
Ozan Pamir | ||
Interim Chief Financial Officer | ||
(Principal Financial Officer and Principal Accounting Officer) | ||
Date: August 9, 2022 |